| 2024-06-18 | Gossamer Bio, Inc. GOSS | COO/CFO | 100,000 0.0512% | $0.59 | $59,110 | +36.07% | ||
| 2024-03-27 | Sale | Gossamer Bio, Inc. GOSS | COO/CFO | 6,430 0.0028% | $1.16 | $7,431 | -37.79% | |
| 2023-11-13 | Gossamer Bio, Inc. GOSS | COO/CFO | 200,000 0.0795% | $0.56 | $112,880 | +36.49% | ||
| 2023-04-04 | Gossamer Bio, Inc. GOSS | COO/CFO | 55,000 0.0583% | $1.02 | $56,095 | +3.45% | ||
| 2022-07-15 | Gossamer Bio, Inc. GOSS | COO/CFO | 13,869 0.0099% | $7.21 | $99,995 | -79.92% | ||
| 2022-03-23 | Sale | Gossamer Bio, Inc. GOSS | COO/CFO | 10,722 0.0143% | $8.91 | $95,587 | -4.09% | |
| 2021-03-23 | Sale | Gossamer Bio, Inc. GOSS | Chief Financial Officer | 5,490 0.0077% | $9.48 | $52,046 | +1.54% | |
| 2020-10-14 | Gossamer Bio, Inc. GOSS | Chief Financial Officer | 6,000 0.0094% | $10.01 | $60,072 | -1.07% | ||
| 2020-06-23 | Gossamer Bio, Inc. GOSS | Chief Financial Officer | 4,000 0.0061% | $12.96 | $51,845 | -21.51% | ||
| 2019-12-03 | Protagonist Therapeutics, Inc. PTGX | director | 16,000 0.0705% | $5.70 | $91,240 | +243.28% | ||
| 2019-09-26 | Gossamer Bio, Inc. GOSS | Chief Financial Officer | 2,242 0.0019% | $8.39 | $18,810 | -14.76% | ||
| 2019-05-30 | Gossamer Bio, Inc. GOSS | Chief Financial Officer | 2,000 0.0017% | $9.35 | $18,700 | -11.88% | ||
| 2019-02-12 | Gossamer Bio, Inc. GOSS | Chief Financial Officer | 12,000 0.0286% | $16.00 | $192,000 | +6.27% | ||
| 2017-05-16 | Protagonist Therapeutics, Inc. PTGX | director | 10,000 0.0357% | $6.46 | $64,566 | +46.97% |